INS and corneal disorder: The limiting aspects pertaining to thestorage and delivery of the small and unstable insulin peptide to the ocularsurface have been addressed using nanotechnology, where the number ofmicroparticles, stably enveloping the therapeutic molecule, and the time tomodulate the wound healing process can lead to a promising strategy fortreating corneal diseases and dry eye disease(150,156).